Company or ticker...

PTC Therapeutics

PTC develops medicines for rare genetic and neuromuscular diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

PTCT

6.1B

7.5

n/a

-3.42%

Key Facts

M. Cap

PS

PE

YTD

6.1B

7.5

n/a

-3.42%

10MA

20MA

50MA

200MA

$PTCT